ArticleScientific reports2025
Dosimetric and clinical outcomes study of occult uterine tandem imperfect implantation in HDR-brachytherapy for cervical cancer.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- RE: Efficacy of medial needles in mitigating dose deficits from sub-optimally inserted tandems in cervical interstitial brachytherapy.Journal of contemporary brachytherapy · 2025Article
- Efficacy of medial needles in mitigating dose deficits from sub-optimally inserted tandems in cervical interstitial brachytherapy.Journal of contemporary brachytherapy · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
To investigate the ramifications of dose alterations and clinical outcomes linked to imperfect uterine tandem implantation within high dose rate brachytherapy (HDR-brachytherapy) for cervical cancer. A retrospective analysis was conducted on imperfect intrauterine insertion images from November 2020 to July 2021. The physicist reconfigured two-dimensions (2D) and three-dimensions (3D) plans based on prescription (6 Gy) for both the imperfection (IM) and perfect (PER) implantation. A paired t-test was employed to assess (reference volume of clinical target volume) CTV
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.